Home > Insider Trading > Filing (0000950170-25-069248)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884624	Orthofix Medical Inc.	OFIX	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1296974	Lee Alan Bazaar	3451 Plano Parkway Lewisville TX 75056		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-09	1,990	$12.62	26,733	No	4	P	Direct
Common Stock	Acquisiton	2025-05-12	2,000	$12.59	28,733	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Reflects the weighted average purchase price. The range of prices for these transactions was $12.56 to $12.68. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 24,088 previously reported deferred stock units and an aggregate of 655 shares acquired under Orthofix's Stock Purchase Plan on 10/31/2024 and 4/30/2025.
Reflects the weighted average purchase price. The range of prices for these transactions was $12.55 to $12.60. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.